Radiology case reports · 2022
Cerebellar infarction risk in a mild COVID-19 case.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kabashi Antigona, Fero Henri, Gjini Artiona, Dhimitri Diana, Spahiu Mimoza, Hyseni Fjolla, Harizi Edlira, Shemsi Kledisa, Vokshi Valon, Decka Arlind, Amin Asm Al, Ataullah Ahm, Capi Livia, Jahanian Sepideh, Nasir Fareeha, Ayala Ivan N, Musa Juna, Shatri Jeton, Dedushi Kreshnike, Leniqi Florim, Hyseni Guri
Аннотация
Thrombotic events in SARS-COV-2 disease patients are frequent, especially in patients with comorbidities such as heart failure, hypertension, cancer, diabetes mellitus, kidney failure, vascular disease, and other pulmonary illnesses. In severe cases, in particular those of hospitalized patients with other comorbidities, the development of thrombotic events in spite of anticoagulation therapy has been observed. The main thrombotic events are pulmonary thromboembolism, cerebral ischemic stroke, and peripheral artery thrombosis. Despite the severity of SARS-COV-2 disease, some patients with the aforementioned comorbidities develop thrombotic events regardless of the severity of their SARS-COV-2 infection. In this setting, the cerebellum makes no exception as an uncommon, but still possible target for thrombotic events.